Latest Lead News

Cannindah Resources Limited has voluntarily suspended its shares from trading as it prepares to announce a significant capital raising. The suspension is set to last until the announcement or the resumption of trading on August 22.

Peet Limited delivered a robust FY25 performance with a 60% jump in net operating profit and a strong sales pipeline, while initiating a strategic review to capitalize on favorable market conditions.

MA Financial Group reported a robust 30% revenue increase for the first half of 2025, yet statutory net profit fell sharply by 44%, highlighting a complex financial landscape as the firm prepares to acquire IP Generation.

Sonic Healthcare Limited has announced an ordinary dividend of AUD 0.63 per share for the first half of 2025, with a 35% franking component and payment scheduled for mid-September.

Qube Holdings delivered a robust FY25 performance with underlying revenue up 27.3% and a 7.1% dividend increase, despite a significant impairment of its MITCo investment. The company’s diversified logistics and grain trading operations powered growth amid industrial and weather challenges.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Infinity Mining’s re-assay of historic stream sediment samples at its Tanjil Bren Project reveals elevated gold and pathfinder elements, highlighting promising intrusion-related gold system signatures.

Vault Minerals announces that CEO Luke Tonkin will step down within the next 12 months, triggering a leadership transition as the company continues to build on recent operational successes.

Lion Rock Minerals confirms exceptionally pure rutile nuggets at its Minta Rutile Project in Cameroon, with independent verification supporting broad titanium industry applications. Exploration results reveal a growing mineralised footprint exceeding 2,750 km², positioning Minta as a globally significant rutile province.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Peter Warren Automotive Holdings reported a modest revenue increase but a sharp profit decline in FY25, unveiling a new CEO and a refreshed growth strategy to tackle industry challenges.

Insignia Financial has reported a robust FY25 with a 17.6% rise in underlying net profit after tax and a record $330.3 billion in funds under management. The company also unveiled its ambitious strategy to become Australia's leading diversified wealth manager by 2030.